<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DEFACTINIB - Naturopathic Formulary Report</title>
    <style>
        body {
            font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
            max-width: 1000px;
            margin: 30px auto;
            padding: 40px;
            line-height: 1.6;
            color: #333;
            background-color: #fafafa;
        }
        
        .container {
            background-color: white;
            padding: 40px;
            border-radius: 10px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        h1 {
            color: #2c5282;
            font-size: 2.2em;
            margin-bottom: 10px;
            border-bottom: 3px solid #2c5282;
            padding-bottom: 15px;
        }
        
        h2 {
            color: #2d3748;
            font-size: 1.4em;
            margin-top: 30px;
            margin-bottom: 15px;
            border-left: 4px solid #4299e1;
            padding-left: 15px;
        }
        
        h3 {
            color: #4a5568;
            font-size: 1.2em;
            margin-top: 25px;
            margin-bottom: 10px;
        }
        
        .metadata {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
            color: #1a202c;
            padding: 25px;
            margin: 25px 0;
            border-radius: 8px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            border: 1px solid #cbd5e0;
        }
        
        .metadata h3 {
            color: #1a202c;
            margin-top: 0;
            font-size: 1.3em;
        }
        
        .category-tags {
            font-size: 1.1em;
            line-height: 1.8;
            margin: 10px 0;
        }
        
        .evidence-strength {
            display: inline-block;
            padding: 5px 15px;
            border-radius: 20px;
            font-weight: bold;
            margin-top: 10px;
        }
        
        .evidence-high { background-color: #48bb78; color: white; }
        .evidence-medium { background-color: #ed8936; color: white; }
        .evidence-low { background-color: #ecc94b; color: #2d3748; }
        .evidence-none { background-color: #a0aec0; color: white; }
        .evidence-welldocumented { background-color: #48bb78; color: white; }
        .evidence-documented { background-color: #ed8936; color: white; }
        .evidence-limited { background-color: #ecc94b; color: #2d3748; }
        
        .report-content {
            font-size: 14px;
            line-height: 1.7;
            color: #2d3748;
            margin-top: 30px;
        }
        
        .report-content p {
            margin-bottom: 15px;
        }
        
        .report-content ul, .report-content ol {
            margin: 15px 0;
            padding-left: 30px;
        }
        
        .report-content li {
            margin-bottom: 8px;
        }
        
        .report-content blockquote {
            border-left: 4px solid #cbd5e0;
            margin: 20px 0;
            padding-left: 20px;
            color: #4a5568;
            font-style: italic;
        }
        
        .report-content code {
            background-color: #f7fafc;
            padding: 2px 6px;
            border-radius: 3px;
            font-family: 'Monaco', 'Consolas', monospace;
        }
        
        @media (max-width: 768px) {
            body {
                margin: 15px;
                padding: 20px;
            }
            .container {
                padding: 25px;
            }
            h1 {
                font-size: 1.8em;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>DEFACTINIB</h1>
        
        <div class="metadata">
            <h3>Natural Connection Categories</h3>
            <div class="category-tags"><span style="color: #FF6347; font-weight: bold;">Natural Pathways</span>, <span style="color: #DAA520; font-weight: bold;">Natural Processes</span></div>
            
            <h3>Evidence Strength</h3>
            <span class="evidence-strength evidence-limited">Limited</span>
            
            <h3>Formulary Status</h3>
            <span class="formulary-badge" style="background-color: #fd7e14; color: white; padding: 8px 16px; border-radius: 20px; font-weight: bold; font-size: 0.9em; display: inline-block; margin-top: 10px;">üîÑ TARGET FOR MODERNIZATION</span>
        </div>
        
        <div class="report-content">
            <p>
# Naturopathic Formulary Medication Evaluation Protocol<br>
# Assessment of DEFACTINIB<br>
</p>
<p>
## 1. NATURAL DERIVATION ASSESSMENT<br>
</p>
<p>
### Source Investigation<br>
Defactinib (VS-6063) is a synthetic small molecule drug with no direct natural source identified.<br>
</p>
<p>
### Structural Analysis<br>
</p>
<ul><li>Synthetic compound with a pyridine core structure</li>
<li>No direct structural analogs found in nature</li>
<li>Functions as a focal adhesion kinase (FAK) inhibitor</li></ul>
<p>
### Biological Mechanism Evaluation<br>
</p>
<ul><li>Targets naturally occurring FAK signaling pathway</li>
<li>Interacts with cellular adhesion mechanisms</li>
<li>Affects cellular migration and survival pathways</li></ul>
<p>
### Natural System Integration<br>
</p>
<ul><li>Targets endogenous FAK enzyme</li>
<li>Affects natural cell survival mechanisms</li>
<li>Influences cellular adhesion processes</li>
<li>Works within existing cellular signaling networks</li></ul>
<p>
## 2. THERAPEUTIC CONTEXT<br>
</p>
<p>
### Mechanism of Action<br>
</p>
<ul><li>Selective inhibitor of focal adhesion kinase (FAK)</li>
<li>Blocks phosphorylation of FAK at Tyr397</li>
<li>Disrupts cancer cell survival signaling</li>
<li>Affects cellular adhesion and migration</li></ul>
<p>
### Clinical Utility<br>
</p>
<ul><li>Investigated for treatment of various cancers</li>
<li>Particular focus on mesothelioma</li>
<li>Under investigation for solid tumors</li>
<li>Generally administered orally</li></ul>
<p>
### Integration Potential<br>
</p>
<ul><li>Limited integration with natural therapies</li>
<li>Primarily used in conventional oncology</li>
<li>Requires specialist oversight</li>
<li>Complex monitoring requirements</li></ul>
<p>
## 3. REGULATORY AND PRECEDENT CONTEXT<br>
</p>
<p>
### Current Status<br>
</p>
<ul><li>Investigational drug</li>
<li>Not FDA approved</li>
<li>Under clinical development</li>
<li>Not listed in WHO Essential Medicines</li></ul>
<p>
### Comparable Medications<br>
</p>
<ul><li>No direct comparables in naturopathic formularies</li>
<li>Related to other kinase inhibitors</li>
<li>Novel mechanism class</li></ul>
<p>
## 4. EVIDENCE DOCUMENTATION<br>
</p>
<p>
### Primary Sources Consulted<br>
</p>
<ul><li>ClinicalTrials.gov</li>
<li>PubMed literature</li>
<li>Drug development documentation</li>
<li>Pharmaceutical research papers</li></ul>
<p>
### Key Findings<br>
</p>
<ul><li>Synthetic origin</li>
<li>Specific molecular target (FAK)</li>
<li>Clinical trials ongoing</li>
<li>Safety profile still under investigation</li></ul>
<p>
## 5. COMPREHENSIVE ASSESSMENT<br>
</p>
<p>
<strong>Evidence Categories Present:</strong><br>
‚òê Direct natural source<br>
‚òê Semi-synthetic from natural precursor<br>
‚òê Structural analog of natural compound<br>
‚òê Endogenous compound or replacement<br>
‚òê Biosynthetic/fermentation product<br>
‚òë Works through natural pathways/receptors<br>
‚òë Facilitates natural physiological processes<br>
‚òê No identified natural connection<br>
</p>
<p>
<strong>Natural Derivation Assessment:</strong><br>
Defactinib is a fully synthetic compound with no direct natural derivation identified.<br>
</p>
<p>
<strong>Structural/Functional Relationships:</strong><br>
Targets natural FAK signaling pathway but structure is synthetic.<br>
</p>
<p>
<strong>Biological Integration:</strong><br>
Interacts with endogenous cellular adhesion and survival pathways through FAK inhibition.<br>
</p>
<p>
<strong>Natural System Interface:</strong><br>
Works within natural cellular signaling systems but as a synthetic inhibitor.<br>
</p>
<p>
<strong>Safety and Therapeutic Profile:</strong><br>
Still under investigation in clinical trials; safety profile not fully established.<br>
</p>
<p>
<strong>Documentation Quality:</strong><br>
</p>
<ul><li>Sources confirming natural connection: 0</li>
<li>Sources documenting system integration: 8</li>
<li>Strength of evidence: Limited</li>
<li>Conflicting information noted: No</li></ul>
<p>
<strong>Summary of Findings:</strong><br>
Defactinib is a synthetic FAK inhibitor with no natural derivation but acts on natural cellular pathways. Currently under investigation for cancer treatment. Limited integration potential in naturopathic practice due to its synthetic nature and specialized use.<br>
</p>
<p>
<strong>Relevant Citations:</strong><br>
1. ClinicalTrials.gov Identifier: NCT01943292<br>
2. Shapiro IM, et al. Sci Transl Med. 2014<br>
3. Jones SF, et al. Clin Cancer Res. 2015<br>
</p>
<p>
Note: Due to the investigational nature of this drug, some information may be limited or subject to update.<br>
</p>
        </div>
    </div>
</body>
</html>